22 June 2020: Clinical Research
Use of Various Doses of S-Ketamine in Treatment of Depression and Pain in Cervical Carcinoma Patients with Mild/Moderate Depression After Laparoscopic Total Hysterectomy
Jie Wang 1ABC* , Yajun Wang 2BC* , Xudong Xu 3BC* , Sheng Peng 4CD , Feng Xu 5CD* , Peirong Liu 4AEF*DOI: 10.12659/MSM.922028
Med Sci Monit 2020; 26:e922028
Table 1 Clinical characteristics of all patients.
| Variables* | High-dose S-ketamine, n=104 | Low-dose S-ketamine, n=104 | Racemic ketamine, n=104 | Control, n=105 | P value |
|---|---|---|---|---|---|
| Age, year | 48.53±10.0 | 48.11±10.38 | 47.07±10.08 | 46.27±10.83 | 0.383 |
| BMI, kg/m | 21.89±2.37 | 22.11±2.37 | 21.91±2.33 | 22.63±2.39 | 0.082 |
| VAS score | 1.11±0.11 | 1.09±0.12 | 1.08±0.11 | 1.09±0.11 | 0.428 |
| HAMD score | 15.75±4.58 | 16.69±4.96 | 16.20±4.86 | 15.78±4.81 | 0.458 |
| BDNF, ng/mL | 23.24±1.29 | 23.08±1.29 | 23.23±1.36 | 23.23±1.18 | 0.775 |
| 5-HT, ng/mL | 228.83±17.70 | 228.10±16.84 | 226.40±16.91 | 222.87±17.22 | 0.059 |
| * All data in this table are from ANOVA followed by Tukey post hoc test. | |||||